Connect with us

Hi, what are you looking for?

News

Ulta Beauty, Inc. (ULTA) Q2 2023 Earnings Call Transcript

Ulta Beauty, Inc. (NASDAQ:ULTA) Q2 2023 Earnings Conference Call August 24, 2023 4:30 PM ET

Company Participants

Kiley Rawlins – Vice President, Investor Relations

Dave Kimbell – Chief Executive Officer

Scott Settersten – Chief Financial Officer, Treasurer and Assistant Secretary

Kecia Steelman – Chief Operating Officer

Conference Call Participants

Ashley Helgans – Jefferies

Michael Baker – D.A. Davidson

Olivia Tong – Raymond James

Anthony Chukumba – Loop Capital Markets

Christopher Horvers – JPMorgan

Adrienne Yih – Barclays

Kelly Crago – Citi

Kate McShane – Goldman Sachs

Steven Forbes – Guggenheim Securities

Operator

Good afternoon and welcome to Ulta Beauty’s Conference Call to discuss Results for the Second Quarter of Fiscal 2023. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce Ms. Kiley Rawlins, Vice President of Investor Relations. Ms. Rawlins, you may proceed.

Kiley Rawlins

Thanks, Paul. Good afternoon, everyone, and thank you for joining us for a discussion of Ulta Beauty’s results for the second quarter of fiscal 2023. Hosting our call today are Dave Kimbell, Chief Executive Officer; and Scott Settersten, Chief Financial Officer; Kecia Steelman, Chief Operating Officer, will join us for the Q&A session.

Before we begin, I’d like to remind you of the company’s Safe Harbor language. The statements contained in this conference call, which are not historical facts, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those projected in such statements due to a number of risks and uncertainties, all of which are described in the company’s filings with the SEC. We caution you not to place undue reliance on these forward-looking

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech...

Videos

Watch full video on YouTube